fah hospital policy blog

Perspectives on health policy affecting America’s hospitals and the patients we serve.

FAH Announces New Chair-Elect and Board of Directors

October 25, 2016 | FAH Hospital Policy Blog Team

Category: FAH News, Quality

The Federation of American Hospitals chose a new Board of Directors and a Chairman-elect on Tuesday. The board is made up of leaders from FAH’s twelve member companies. “This is an exciting day for the Federation. The health care field is constantly evolving and having these CEO’s contribute their expertise and deep understanding of our industry will only enhance our organization’s ability to effectively answer the challenges facing us now and into the future,” said Chip Kahn, President and CEO of FAH.

Read More »

FAH Leader Talks about “Health Security” in Modern Healthcare Op-Ed

October 17, 2016 | FAH Policy Blog Team

Category: Affordable Care Act, FAH News, Insurance

Today, Modern Healthcare published a commentary authored by Federation of American Hospitals President and CEO Chip Kahn entitled “Upcoming Open Enrollment Offers Opportunity for More Americans to Protect Health, Wealth.” The piece uses a recent study from the research firm Avalere to make the case that health care coverage can protect people “psychologically, physically and fiscally.”

Read More »

FAH, AHA Sponsored Drug Pricing Study Gains National Media Attention

October 13, 2016 | FAH Policy Blog Team

Category: FAH News, Financing, Pharmaceuticals

A new analysis of drug pricing data released on October 11 got the attention of influential policymakers and garnered headlines nationwide after finding that hospital drug costs increased drastically over a two year period.

Read More »

A Dose of Facts: FAH, AHA Examine the Effects of Skyrocketing Drug Prices on Patients and Hospitals

October 11, 2016 | Chip Kahn, President and CEO, FAH and Rick Pollack, President and CEO, AHA

Category: FAH News

The price of prescription drugs has skyrocketed over the past several years. It seems that every day we hear a new report of how the cost of drugs hurts patients. When the price of a two-pack of Epipens jumped from $100 to $600 between 2007 and 2016 – an increase of 500 percent – parents around the country wondered if they would be able to acquire this life-saving medication for their children. When the cost of the infection-control drug Daraprim went from $13.50 to $750 a pill overnight, real patients ended up in the hospital when they could not follow their treatment regimens.

Read More »